cGMP Manufacturing is a key step to ensure that drugs comply with strict quality standards and regulations throughout the entire production process so that they can safely and effectively enter stages such as clinical trials, release, and commercialization. Leveraging years of accumulated experience in formulation manufacturing and successful projects, CD Formulation is committed to helping you achieve scale-up of your therapeutic protein and peptide formulations, and ultimately reach commercial production for marketing. We utilize a comprehensive cGMP formulation pilot plant dedicated to process development and optimization, preclinical trial batch drug production, and commercial production scale-up technology transfer to safely advance your drug product.
CD Formulation is a technology-driven biopharmaceutical CDMO that provides integrated end-to-end services to support the entire development of therapeutic protein and peptide drugs, including pre-formulation studies, formulation development, analytical method development and validation, QbD-based process development, and commercial manufacturing and packaging, among others.
In our 4,000-square-foot GMP manufacturing facility, we develop and manufacture a variety of therapeutic line protein and peptide formulations to support preclinical and clinical trials. We are committed to being a top performer, from our facilities to our employees. We provide consistent cGMP proteins and peptides formulation cGMP manufacturing services to the highest standards and on your schedule.
We can handle a variety of dosage forms, from low-volume production for preclinical trials to high-volume commercialization, including:
Dosage Forms We Manufacture
Manufacturing Capabilities
Furthermore, our biopharmaceutical manufacturing team has extensive experience working with global regulatory authorities such as Europe (Ph.Eur.), the United States (USP), and Japan (JP), ensuring you receive comprehensive quality control services.
cGMP Proteins & Peptides Formulation Highlights
Published Data
Technology: The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing
Journal: Anal Bioanal Chem.
IF: 4.3
Published: 2022
Results:
As part of the Process Analytical Technology (PAT) strategy, Raman spectroscopy is used successfully in bioprocessing in cGMP process control. The authors discuss new frontiers in extending these successes in upstream from scale-down to commercial manufacturing.Furthermore, the method for laboratory and in-line measurements of protein quality, including higher-order structure and composition modifications, were provided to support formulation development.
Fig. 2 Raman Spectrometer for biopharmaceuticals development and manufacturing. (Esmonde-White KA, et al., 2022)
Comprised of experienced protein chemists and formulation engineers, CD Formulation focuses on developing and producing protein and peptide drugs that meet global cGMP standards for customers to address complex biotechnology challenges. Please don’t hesitate to contact us if you are interested in our services. We look forward to cooperating with you.
References